Results 91 to 100 of about 4,210,891 (389)

Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury. [PDF]

, 2018
Cannabis is an effective treatment for pain following spinal cord injury that should be available to patients and researchers. The major argument against the rescheduling of cannabis is that the published research is not convincing.
Graves, PhD, Daniel E.
core   +1 more source

Developments and Changes in Primary Public Health Outcome Indicators Associated with the Legalization of Non-Medical Cannabis Use and Supply in Canada (2018): A Comprehensive Overview

International Journal of Mental Health and Addiction, 2022
Canada legalized non-medical cannabis use and supply for adults in 2018. We examined developments and changes associated with the legalization policy reform on key indicators for public health, namely cannabis (including frequent/problematic) use ...
Himani Boury, W. Hall, B. Fischer
semanticscholar   +1 more source

Neuroprotective Effect of Cannabidiol Against Rotenone in Hippocampal Neuron Culture

Chemistry – An Asian Journal, EarlyView.
(–)‐Cannabidiol (CBD) protects primary hippocampal neurons from rotenone, a mitochondrial complex I inhibitor that causes cell death. CBD preserves neuronal viability and morphology, with antagonist assays showing that transient receptor potential vanilloid 1 (TRPV1) mediates this neuroprotective effect.
Seoin Yang, Hyunwoo Choi, Jungnam Kim, Insung S. Choi   +3 more
wiley   +1 more source

Maltese health and social wellbeing student knowledge, attitudes and beliefs about medical cannabis

Complementary Therapies in Medicine, 2021
Given the recent emergence of medical cannabis legalization in Malta, the objective of this study was to assess knowledge, attitudes, and beliefs about medical cannabis among a sample of Maltese students. The sample comprised 327 students enrolled in the
Jamie Bonnici, Marilyn Clark
doaj   +1 more source

U.S. policy responses to calls for the medical use of Cannabis [PDF]

, 2015
This paper discusses the evolution of U.S. policy responses to calls to allow patients to use cannabis for medical purposes. It first summarizes the research evidence on the safety and efficacy of cannabinoids for various medical uses.
Hall, Wayne
core  

Cannabis use and hypomania in young people: a prospective analysis [PDF]

, 2017
Background: Cannabis use in young people is common and associated with psychiatric disorders. However, the prospective link between cannabis use and bipolar disorder symptoms has rarely been investigated.
Bebbington, Paul, Marwaha, Steven, Smith, Daniel, Winsper, Catherine   +3 more
core   +4 more sources

Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients

JAMA Network Open, 2022
This survey study compares the use of cannabis for medical purposes as reported in electronic health records (EHRs) with use reported in a confidential survey.
Gwen T Lapham, Theresa E. Matson, D. Carrell, J. Bobb, Casey Luce, Malia M Oliver, Udi E. Ghitza, Clarissa Hsu, Kendall Browne, I. Binswanger, Cynthia I. Campbell, A. Saxon, R. Vandrey, Gillian L. Schauer, R. Pacula, M. Horberg, S. Bailey, E. McClure, K. Bradley   +18 more
semanticscholar   +1 more source

Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium Valproate

Autism Research, EarlyView.
ABSTRACT Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication deficits, repetitive behaviors, and sensory abnormalities. Sodium valproate (VPA) exposure during embryonic development is a well‐established preclinical model for ASD, leading to increased oxidative stress in the developing brain, including ...
Karla C. M. Costa, Tamires A. V. Brigante, Pedro H. C. Lirio, Gabriel G. Fernandes, Franciele F. Scarante, Davi S. Scomparin, Rafael R. Ferreira, Maria A. Vicente, Flavia R. Abe, Francisco S. Guimarães, Jaime E. C. Hallak, Jose A. Crippa, Danielle P. de Oliveira, Alline C. Campos   +13 more
wiley   +1 more source

Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center

Harm Reduction Journal
Background Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However, access to medical cannabis remains limited, particularly for underserved populations. To understand how patients experience medical
Eloise W. Freitag, Yuval Zolotov, Jayabhargav Annam, Jaqueline Labins, Jaclyn M. Yamada, Syeda Masharab Jillani, Julia H. Arnsten, Deepika E. Slawek   +7 more
doaj   +1 more source

“Guarding their practice”: a descriptive study of Canadian nursing policies and education related to medical cannabis

BMC Nursing, 2019
Background In Canada, federal regulations allow Nurse Practitioners (NPs) to authorize medical cannabis. Nursing regulatory bodies, however, have been hesitant to include medical cannabis within NPs’ scope of practice.
Lynda G. Balneaves, Abeer A. Alraja
doaj   +1 more source